← Nippon India Mutual Fund

Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option

Equity Data as of Oct 2026 Comparing Sep 2026 → Oct 2026
Share: WhatsApp X
Stocks Held
37
Oct 2026
Equity Holdings
₹9,051.24 Cr
Equity only, excl. debt & cash
AAUM
₹9,023.03 Cr
Jul-Sep 2026 · Direct + Regular
Top 5 Weight
36.8%
Moderate
Top 10 Weight
57.2%
Moderate
Changes
36
1 new · 0 exits
Top Sector
Pharmaceuticals & Biotechnology
75.0% of portfolio
Launch Date
10 May 2004
10+ year track record

AAUM (Average Assets Under Management) of ₹9,023.03 Cr for Jul-Sep 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.

📋 What Happened This Month Nippon India Pharma Fund added 1 new stock to its portfolio this month. The biggest new buy was Natco Pharma Limited (Pharmaceuticals & Biotechnology) at 0.90% weight. Among existing holdings, Fortis Healthcare Limited saw the biggest increase — now at 2.25% of the portfolio. Divi's Laboratories Limited was trimmed the most, now at 6.73%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 75.0%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.
Sector Shift Industry allocation month-over-month
Aug 2026 → Sep 2026
Sector Prev Curr ▼ Delta
Pharmaceuticals & Biotechnology 74.0% 74.0% ● 0.0%
Healthcare Services 21.1% 20.3% ▼ -0.8%
Retailing 2.5% 2.5% ● +0.0%
Healthcare Equipment & Supplies 0.4% 0.5% ▲ +0.1%
Sep 2026 → Oct 2026
Sector Prev Curr ▼ Delta
Pharmaceuticals & Biotechnology 74.0% 75.0% ▲ +1.0%
Healthcare Services 20.3% 21.8% ▲ +1.6%
Retailing 2.5% 2.3% ▼ -0.3%
Healthcare Equipment & Supplies 0.5% 0.5% ● 0.0%
🟢
Biggest New Buy
Natco Pharma Limited
0.90% weight · Pharmaceuticals & Biotechnology
↑
Biggest Add
Fortis Healthcare Limited
+1.12% · now 2.25%
↓
Biggest Trim
Divi's Laboratories Limited
-0.37% · now 6.73%
🤝 Other funds also bought this month
Natco Pharma Limited 24 funds
Natco Pharma Limited
ICICI Prudential Contra Fund
Bank of India Value Fund Direct Growth
ICICI Prudential Balanced Hybrid Fund + more

What Changed in the Portfolio This Month?

Comparing Sep 2026 → Oct 2026

Sep 2026 → Oct 2026
🟢 1 New Entry ↑ 15 Increased ↓ 20 Decreased
#StockSectorWeight (Oct 2026)
1
Natco Pharma Limited
₹81.37 Cr
Pharmaceuticals & Biotechnology 0.90%
#StockSectorSep 2026Oct 2026Change
1
Fortis Healthcare Limited
₹204.04 Cr
Healthcare Services 1.13% 2.25% +1.12%
2
Dr. Reddy's Laboratories Limited
₹556.82 Cr
Pharmaceuticals & Biotechnology 5.45% 6.13% +0.68%
3
Max Healthcare Institute Limited
₹300.84 Cr
Healthcare Services 2.70% 3.31% +0.61%
4
Piramal Pharma Limited
₹237.41 Cr
Pharmaceuticals & Biotechnology 2.24% 2.61% +0.37%
5
Apollo Hospitals Enterprise Limited
₹463.62 Cr
Healthcare Services 4.89% 5.10% +0.21%
6
Cipla Limited
₹564.67 Cr
Pharmaceuticals & Biotechnology 6.01% 6.21% +0.20%
7
Gland Pharma Limited
₹247.84 Cr
Pharmaceuticals & Biotechnology 2.53% 2.73% +0.20%
8
Syngene International Limited
₹141.01 Cr
Healthcare Services 1.40% 1.55% +0.15%
9
Sai Life Sciences Limited
₹366.91 Cr
Pharmaceuticals & Biotechnology 3.92% 4.04% +0.12%
10
Anthem Biosciences Limited
₹117.69 Cr
Pharmaceuticals & Biotechnology 1.19% 1.30% +0.11%
#StockSectorSep 2026Oct 2026Change
1
Divi's Laboratories Limited
₹611.99 Cr
Pharmaceuticals & Biotechnology 7.10% 6.73% -0.37%
2
Thyrocare Technologies Limited
₹175.13 Cr
Healthcare Services 2.24% 1.93% -0.31%
3
GlaxoSmithKline Pharmaceuticals Limited
₹256.78 Cr
Pharmaceuticals & Biotechnology 3.11% 2.83% -0.28%
4
MedPlus Health Services Limited
₹205.59 Cr
Retailing 2.53% 2.26% -0.27%
5
Aurobindo Pharma Limited
₹128.93 Cr
Pharmaceuticals & Biotechnology 1.65% 1.42% -0.23%
6
Sun Pharmaceutical Industries Limited
₹1,049.97 Cr
Pharmaceuticals & Biotechnology 11.71% 11.55% -0.16%
7
Suraksha Diagnostic Ltd
₹123.26 Cr
Healthcare Services 1.51% 1.36% -0.15%
8
Akums Drugs and Pharmaceuticals Limited
₹98.90 Cr
Pharmaceuticals & Biotechnology 1.21% 1.09% -0.12%
9
Abbott India Limited
₹201.35 Cr
Pharmaceuticals & Biotechnology 2.32% 2.22% -0.10%
10
Indoco Remedies Ltd
₹34.40 Cr
Pharmaceuticals & Biotechnology 0.48% 0.38% -0.10%

What Stocks Does This Fund Hold?

37 stocks — Oct 2026

# Stock Sector Cap Weight & Value
1
₹1,049.97 Cr
Pharmaceuticals & Biotechnology
11.55%
2
₹611.99 Cr
Pharmaceuticals & Biotechnology
6.73%
3
₹564.67 Cr
Pharmaceuticals & Biotechnology
6.21%
4
₹559.86 Cr
Pharmaceuticals & Biotechnology
6.16%
5
₹556.82 Cr
Pharmaceuticals & Biotechnology
6.13%
6
₹463.62 Cr
Healthcare Services
5.10%
7
₹399.74 Cr
Pharmaceuticals & Biotechnology
4.40%
8
₹366.91 Cr
Pharmaceuticals & Biotechnology
4.04%
9
₹320.68 Cr
Pharmaceuticals & Biotechnology
3.53%
10
₹300.84 Cr
Healthcare Services
3.31%
🏆 Top stocks held by Equity funds
See which stocks all active Equity fund managers are buying — ranked by total value invested
→
🏦 Nippon India Mutual Fund — Portfolio & Holdings
See all funds managed by Nippon India Mutual Fund — conviction stocks, monthly entries & exits
→

Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.

Found a discrepancy or have feedback? Contact Us — we read every message personally.